Navigation Links
Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx
Date:9/18/2013

exity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen develops product candidates internally and through licensing collaborations, partnerships, joint ventures and acquisitions.   Product candidates that are derived from relationships or acquisitions may be subject to disputes between the parties or may prove to be not as effective or as safe as Amgen may have believed at the time of entering into such relationship. Also, Amgen or others could identify safety, side effects or manufacturing problems with Amgen's products after they are on the market.  Amgen's business may be impacted by government investigations, litigation and product liability claims.  If Amgen fails to meet the compliance obligations in the corporate integrity agreement between Amgen and the U.S. government, it could become subject to significant sanctions.  Amgen depends on third parties for a significant portion of its manufacturing capacity for the supply of certain of its current and future products and limits on supply may constrain sales of certain of its current products and product candidate development.

In addition, sales of Amgen's products are affected by the reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of Amgen's products.  I
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
2. Amgen To Participate At Citis 8th Annual Biotech Conference
3. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
4. Amgen to Highlight New Data at Upcoming ESC Congress 2013
5. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
6. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
7. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
8. Amgens Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
9. Amgen Announces Webcast of 2013 Second Quarter Financial Results
10. Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
11. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... COTTAGE, New York , July 30, 2015 /PRNewswire/ ... release of its latest report titled, "Continuous Glucose Monitoring ... - 2020". According to the report, the global continuous ... Mn in 2014 and is expected to reach US$ ... during the forecast period, 2015 to 2020. ...
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... Sciences University, Augusta, GA  exhibited a poster ... Research in Los Angeles, in which their clinical study ... IV Connector significantly decreased the incidence of catheter-related ... to a simple split septum with negative displacement IV ...
... Food and Drug Administration is warning that terbutaline administered by ... in pregnant women for prevention or prolonged (beyond 48-72 hours) ... maternal heart problems and death. In addition, oral terbutaline tablets ... labor. The FDA is requiring the addition of a Boxed ...
Cached Medicine Technology:New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92% 2New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92% 3FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor 2FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor 3
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... the five new industry players to know in predictive health analytics , ... machine learning technologies. The firm creates predictive software that targets patient and population ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug and alcohol ... North Conference Center. The medical community, social workers, law enforcement, and government officials ... aligned in the effort to better understand and combat sex trafficking. Lead by ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... According to the article ... floor of the Pasadena courthouse was contained and extinguished by the city’s fire department before ... in the building at the time of the fire, and it was a fire alarm ...
(Date:7/31/2015)... Texas (PRWEB) , ... July 31, 2015 , ... As ... Sitter believes community involvement and support of animal welfare organizations is essential to the ... the third consecutive year in the National Association of Professional Pet Sitters (NAPPS) annual ...
(Date:7/31/2015)... ... 31, 2015 , ... Girl Scouts of Historic Georgia and Peach State Health ... Scout "Be a Friend First" program. Representatives from Peach State Health Plan presented a ... Health Plan and our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. ...
Breaking Medicine News(10 mins):Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... FRIDAY, Jan. 14 (HealthDay News) -- Exposure to bright artificial ... your sleep and may increase the risk of high blood ... included 116 healthy participants, aged 18 to 30, who were ... eight hours before bedtime for five consecutive days. Blood plasma ...
... 2011) Based on a survey of thousands of ... physician-researchers from Los Angles Biomedical Research Institute at Harbor-UCLA ... a guide to the top 1 percent of physicians ... "America,s Top Doctors," chose another 16 LA BioMed physician-researchers ...
... Ont., Jan. 13, 2011Patients who must return to dialysis ... on home dialysis as hospital dialysis, but few choose ... Perl, a nephrologist at St. Michael,s Hospital. Despite ... an increasing number of patients return to dialysis. These ...
... study by Ohio State University cancer researchers provides a ... of targeted agents, one that inhibits an overactive, cancer-causing ... that silence genes that normally prevent cancer. Both types ... in clinical trials, the researchers note. The findings, published ...
... The more you walk, the lower your risk of diabetes, ... who participated in a study to map diabetes levels across ... at the start of the study and provided details about ... given a pedometer and instructed how to use it. ...
... 2011 AIUM Annual Convention and Preconvention Program, the only ... all disciplines of medical ultrasound, to be held April ... convention program incorporates an unprecedented selection of scientific research ... a focus on emerging applications and patient safety. ...
Cached Medicine News:Health News:Bright Lights at Night May Raise Diabetes Risk 2Health News:LA BioMed researchers among 'America's Top Doctors' 2Health News:Home dialysis effective for kidney patients after transplant fails 2Health News:Study provides molecular rationale for combining targeted agents to treat breast cancer 2Health News:The More You Walk, the Lower Your Diabetes Risk: Study 2Health News:AIUM unveils original features at 2011 convention 2
... stabilizer is an example of advanced technology ... the compression and comfort of a soft ... an ankle stirrup. A plastic exoskeleton ... fabric, forming a network of strategically placed ...
... with three regulated communicative chambers. It's one ... of low profile pneumatics to dramatically increase ... in other stirrups. The "slow rebound" air ... is enclosed and protected to prevent puncture. ...
... X-Brace is a cost effective stirrup designed to ... rehabilitation. It is lower in profile than other ... increasing potential patient compliance. The X-Brace offers the ... instep, and everts the foot. This allows the ...
... has a rigid shell with a vacuum liner ... The VacoSplint is a non-weight bearing splint. Once ... should transfer to the STORM walker boot., ... liner from the STORM and insert the vacuum ...
Medicine Products: